\n \nSulfasalazine USP \n \nComposition :?Sulfasalazine USP 500mg Enteric Coated Tablet. \n \nIndication :?Rheumatoid arthritis & Juvenile arthritis :?Sulfasalazine is indicated for Rheumatic arthritis and Juvenile arthritis which has failed to responded to nonsteroidal anti-inflammatory drugs (NSAIDs). \n \nUlcerative colitis and Crohn's disease : Sulfasalazine is also indicated for the treatment and management of severe and acute attacks of Ulcerative colitis, and in the treatment of Crohn's disease, especially in patients with colonic involvement. \n \n \nDosage and administration :?The dosage of Sulfasalazine (Sulfacol) tablets should be individually adjusted according to the patient's tolerance and response to the treatment and taken in evenly divided doses preferably after meals. Please see prescribing description for more information. \n \nPregnancy and lactation :?Pregnancy catergory B. Sulfasalazine should be administered during pregnancy only if the potential benefits outweigh the potential risk to the fetus. Caution should be exercised when sulfasalazine is administered to a nursing mother. \n \nPacking :?3x10's tablets in blister pack. \n \n